Cristal Delivery’s lead technology comprises the transient conjugation of bioactive low molecular weight compounds into biodegradable nanoparticles, CriPec-M. The combination of CriPec-M’s nanoparticle’s stabilisation with transiently stably entrapped drugs is one of its kind and assures the following innovative formulation properties:
Release rates are designed such as to meet therapeutic requirements, whereby sustained exposure over one day or up to several weeks can be achieved, dependent on the route of administration. The formulation benefits of CriPec-M are depicted below.
For patients and clinicians, the corresponding beneficial clinical advantages result in an improved therapeutic index, enhancement of survival rate and improved quality of life.
